DK0434394T3 - Forbindelser til behandling af inflammatorisk tarmsygdom - Google Patents

Forbindelser til behandling af inflammatorisk tarmsygdom

Info

Publication number
DK0434394T3
DK0434394T3 DK90313923T DK90313923T DK0434394T3 DK 0434394 T3 DK0434394 T3 DK 0434394T3 DK 90313923 T DK90313923 T DK 90313923T DK 90313923 T DK90313923 T DK 90313923T DK 0434394 T3 DK0434394 T3 DK 0434394T3
Authority
DK
Denmark
Prior art keywords
inflammatory bowel
bowel disease
compounds
treatment
benzyl
Prior art date
Application number
DK90313923T
Other languages
Danish (da)
English (en)
Inventor
Jaswant Singh Gidda
Jill Ann Panetta
Michael Leroy Phillips
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0434394T3 publication Critical patent/DK0434394T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Eye Examination Apparatus (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Surgical Instruments (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90313923T 1989-12-21 1990-12-19 Forbindelser til behandling af inflammatorisk tarmsygdom DK0434394T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45420389A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
DK0434394T3 true DK0434394T3 (da) 1998-12-14

Family

ID=23803709

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90313923T DK0434394T3 (da) 1989-12-21 1990-12-19 Forbindelser til behandling af inflammatorisk tarmsygdom

Country Status (22)

Country Link
EP (1) EP0434394B1 (ja)
JP (1) JP3036853B2 (ja)
KR (1) KR0176243B1 (ja)
CN (1) CN1029846C (ja)
AT (1) ATE169294T1 (ja)
AU (1) AU639734B2 (ja)
CA (1) CA2032330C (ja)
CY (1) CY2100B1 (ja)
DE (1) DE69032537T2 (ja)
DK (1) DK0434394T3 (ja)
ES (1) ES2121748T3 (ja)
FI (2) FI104251B1 (ja)
HU (1) HU216732B (ja)
IE (1) IE904633A1 (ja)
IL (3) IL108962A (ja)
MX (1) MX23803A (ja)
NO (1) NO300458B1 (ja)
NZ (1) NZ236472A (ja)
PT (1) PT96198B (ja)
RU (2) RU2036915C1 (ja)
YU (1) YU240690A (ja)
ZA (1) ZA9010041B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87339A1 (fr) * 1988-09-20 1990-04-06 Oreal Nouveaux derives de benzylidene-cyclanones,leur procede de preparation,leur utilisation en tant qu'agents anti-oxydants et comme filtres solaires,compositions cosmetiques et pharmaceutiques les contenant
US5143928A (en) * 1990-03-27 1992-09-01 Warner-Lambert Company 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents
ZA936492B (en) * 1992-09-10 1995-03-02 Lilly Co Eli Compounds useful as hypoglycemic agents and for treating Alzheimer's disease.
DK0595546T3 (da) * 1992-10-28 1996-04-15 Shionogi & Co Benzylidenderivater
US6251928B1 (en) 1994-03-16 2001-06-26 Eli Lilly And Company Treatment of alzheimer's disease employing inhibitors of cathepsin D
US5563277A (en) * 1994-12-21 1996-10-08 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
EP0761657B1 (en) * 1995-09-07 2000-05-24 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
IN182320B (ja) * 1995-09-07 1999-03-20 Lilly Co Eli
EP0779282A1 (en) * 1995-12-14 1997-06-18 Eli Lilly And Company Thiomorpholinone compounds for treating multiple sclerosis
US5981523A (en) * 1996-02-05 1999-11-09 Eli Lilly And Company Compounds and methods for treating multiple sclerosis
US6063799A (en) * 1996-09-03 2000-05-16 Eli Lilly And Company Alternate crystal form of Tazofelone
US6005142A (en) 1996-09-03 1999-12-21 Eli Lilly And Company Process for preparing benzyl-substituted rhodanine derivatives
WO2000018746A1 (en) * 1998-09-30 2000-04-06 Roche Diagnostics Gmbh Thiazolidine derivatives for the treatment and prevention of metabolic bone disorders
EP1117655A1 (en) 1998-09-30 2001-07-25 Angelika Esswein Rhodanine carboxylic acid derivatives for the treatment and prevention of metabolic bone disorders
AU6330999A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Rhodanine derivatives for the treatment and prevention of metabolic bone disorders
US7235573B2 (en) 2002-09-30 2007-06-26 The Regents Of The University Of California Methods of treating secretory diarrhea using cystic fibrosis transmembrane conductance regulator protein inhibitors
NZ538809A (en) * 2002-09-30 2008-06-30 Univ California Thiazolidinone cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof
AU2002953533A0 (en) 2002-12-24 2003-01-16 Arthron Limited Fc receptor modulating compounds and compositions
JP5778755B2 (ja) * 2010-04-15 2015-09-16 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung ヒドロキノンの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1285572C (en) * 1985-08-09 1991-07-02 Jill Ann Panetta Di-t-butylphenol compounds
IE62214B1 (en) * 1988-05-25 1995-01-11 Warner Lambert Co Arylmethylenyl derivatives of thiazolidinones, imidazolidinones and oxazolidinones useful as antiallergy agents and antiinflammatory agents
DE69027472T2 (de) * 1989-04-07 1996-12-05 Lilly Co Eli Arylsubstituierte Rhodaninderivate

Also Published As

Publication number Publication date
FI104251B (fi) 1999-12-15
JP3036853B2 (ja) 2000-04-24
AU639734B2 (en) 1993-08-05
ES2121748T3 (es) 1998-12-16
NZ236472A (en) 1993-03-26
JPH04279573A (ja) 1992-10-05
IL108962A0 (en) 1994-06-24
RU2050355C1 (ru) 1995-12-20
CA2032330C (en) 2001-05-08
CN1029846C (zh) 1995-09-27
PT96198B (pt) 1998-05-29
ATE169294T1 (de) 1998-08-15
PT96198A (pt) 1991-09-30
EP0434394B1 (en) 1998-08-05
IL96654A (en) 1995-06-29
YU240690A (sh) 1992-12-21
NO300458B1 (no) 1997-06-02
FI906273A0 (fi) 1990-12-19
CA2032330A1 (en) 1991-06-22
DE69032537D1 (de) 1998-09-10
HU908368D0 (en) 1991-07-29
FI906273A (fi) 1991-06-22
MX23803A (es) 1994-02-28
ZA9010041B (en) 1992-08-26
RU2036915C1 (ru) 1995-06-09
NO905478L (no) 1991-06-24
IE904633A1 (en) 1991-07-17
AU6826690A (en) 1991-06-27
IL108962A (en) 1996-12-05
NO905478D0 (no) 1990-12-19
EP0434394A3 (en) 1992-01-08
CN1052668A (zh) 1991-07-03
EP0434394A2 (en) 1991-06-26
DE69032537T2 (de) 1999-01-21
FI19991698A (fi) 1999-08-10
KR0176243B1 (ko) 1999-03-20
CY2100B1 (en) 2002-04-05
HUT59915A (en) 1992-07-28
HU216732B (hu) 1999-08-30
FI104251B1 (fi) 1999-12-15
KR910011812A (ko) 1991-08-07

Similar Documents

Publication Publication Date Title
DK0434394T3 (da) Forbindelser til behandling af inflammatorisk tarmsygdom
LU90999I2 (fr) Escitalopram et ses sels pharmaceutiquement acceptables (cipralex)
NO179518C (no) AnalogifremgangsmÕte for fremstilling av 2- hydroksymetylcytosin-substituerte 1,3-oksatiolaner
DK0836601T3 (da) Fremgangsmåde til optisk oprensning af enantiomert beriget benzimidasolderivater
AT383130B (de) Verfahren zur herstellung von an c1 und c2 verschieden substituierten phosphatidylcholinen und phosphatidylethanolaminen ueber die neuen verbindungen 1-0-tritylglycerophosphocholin beziehungsweise (1-0,n-ditrityl)-glycerophosphoethanolamin
NO179612C (no) Analogifremgangsmåte for fremstilling av 3-arylkarbonyl-1-aminoalkyl-1H-indol-forbindelser
PT97547A (pt) Processo para a preparacao de novas pirido {2,3-f}{1,4}tiazepinas e pirido {3,2-b}{1,5}benzotiazepinas e de composicoes farmaceuticas que as contem
ATE65779T1 (de) Verfahren zur herstellung von carbinolderivaten.
DE69527802D1 (de) Verfahren zur herstellung von benzyl-substituierten rhodanin derivaten
DK0431305T3 (da) Fremgangsmåde til fremstilling af molluskicide 2,4,5-tribrompyrrol-3-carbonitriler
CS53688A2 (en) Method of new substituted 3-phenyl-7h-thiazolo/3,2-b//1,2,4/triazine -7-ons production
FR2647959B1 (fr) Procede de fabrication simultanee de transistors mos a canal n et de transistors bipolaires verticaux pnp
NO950952D0 (no) Fremgangsmåte for fremstilling av pilokarpin
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
DK0425980T3 (da) Fremgangsmåde til enantiomerspaltning af benzopyranderivater
ATE193284T1 (de) Verfahren zur herstellung von benzylsubstituierten rhodaninederivaten
ATE200664T1 (de) Neue enantiomerenreine pyridylcycloalkylethylamine und deren salze sowie verfahren zu ihrer herstellung
HU9203625D0 (en) Stereoselective process for producing optical isomers of 1-benzoyl-4-hydroxi-5-(1-phenyl-ethyl)-amino-1,2,2a,3,4,5-hexahydrobenz/cd/-indole